The Navigator Program
It is the vision of First Flight Venture Center, FFVC, to be an important catalyst in the success of our high-science, high-impact entrepreneurial companies. We do this through multiple programs that provide tailored resources, guidance, connections, and support required for their navigation of the global marketplace.
The Navigator Program at FFVC leverages the talent and experience of seasoned entrepreneurs and executive level individuals, our Navigators, to help FFVC resident companies build successful ventures by serving as trusted advisors. The Navigator’s participation is voluntary and based on their desire to give back to the entrepreneurial community.
A Navigator is paired with a senior executive from a company, allowing the company’s executive to gain from the Navigator’s knowledge and experience, and helping advance the company toward graduation from FFVC. Working with a Navigator is a fundamental element and benefit of the overall FFVC program.
Mr. Gray has assisted companies to plan and execute successful go-to-market strategies for a broad range of diagnostic and therapeutic products across numerous diseases states. His experience includes leading development and launch of novel technologies in diagnostic imaging, endoscopy, surgical instruments, stents and implantables, drug/device combinations, neurodiagnostics, biologics, and pharmaceuticals. Mr. Gray has run high-performing, customer-oriented businesses in range of disease areas and markets including neurology and neurodegenerative diseases, cardiovascular disease and stroke, ophthalmology, oncology, diabetes, gastroenterology, urology, sports medicine and orthopedics, and regenerative medicine. In his most recent assignment, Mr. Gray led commercialization efforts for novel noninvasive biomarkers targeting multiple sclerosis, Alzheimer’s disease and cognitive disorders, Parkinson’s disease and other movement disorders, stroke, and traumatic brain injury. His business activities span all of the major global healthcare markets and he brings insight into local market needs having lived overseas and utilizing his Japanese language skills. Mr. Gray received his B.A. from Earlham College and M.A. in International Business from Columbia University.
In 2015, Damon formed Kaliber Investments and is an owner in the fund. Kaliber Investments is a healthcare investment fund for accredited investors, with an emphasis on small to mid-cap pharmaceutical and biotechnology companies. Damon graduated from George Mason University in 1996 with a Bachelor of Science in biology and began his career in pharmaceuticals. Damon holds an MBA from Duke University’s Fuqua School of Business, the Certified Licensing Professional designation from the Licensing Executive Society and the FINRA Series 65. Damon serves on the board of directors of The Green Chair Project and is a member of the Advisory Board of both Trill Financial and Epicypher.
His most recent CFO experience was with two publicly traded companies in the medical device and energy industries. His management experience includes finance and IT leadership, strategic planning, debt/equity raising and deep M&A expertise. He has deep international experience which started with an expatriate position with Honeywell in Europe.
Mark is on the Board of Military Outreach USA and serves on the Audit Committee for Opportunity International. He was previously on the Board of St. Alexius Medical Center and the Finance Committee for the Alexian Brothers Health System.
Mark received his MBA in IT from the University of Minnesota and his BS in Accounting from The Ohio State University.